328 related articles for article (PubMed ID: 2557900)
1. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
[TBL] [Abstract][Full Text] [Related]
2. Identification of aspartic acid 514 through glutamic acid 542 as a glycoprotein Ib-IX complex receptor recognition sequence in von Willebrand factor. Mechanism of modulation of von Willebrand factor by ristocetin and botrocetin.
Berndt MC; Ward CM; Booth WJ; Castaldi PA; Mazurov AV; Andrews RK
Biochemistry; 1992 Nov; 31(45):11144-51. PubMed ID: 1359905
[TBL] [Abstract][Full Text] [Related]
3. Cross-linking of a monomeric 39/34-kDa dispase fragment of von Willebrand factor (Leu-480/Val-481-Gly-718) to the N-terminal region of the alpha-chain of membrane glycoprotein Ib on intact platelets with bis(sulfosuccinimidyl) suberate.
Andrews RK; Gorman JJ; Booth WJ; Corino GL; Castaldi PA; Berndt MC
Biochemistry; 1989 Oct; 28(21):8326-36. PubMed ID: 2690940
[TBL] [Abstract][Full Text] [Related]
4. Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex.
Berndt MC; Du XP; Booth WJ
Biochemistry; 1988 Jan; 27(2):633-40. PubMed ID: 2450575
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
[TBL] [Abstract][Full Text] [Related]
6. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
Ward CM; Andrews RK; Smith AI; Berndt MC
Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
[TBL] [Abstract][Full Text] [Related]
7. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
[TBL] [Abstract][Full Text] [Related]
8. Identification of a site in the alpha chain of platelet glycoprotein Ib that participates in von Willebrand factor binding.
Vicente V; Houghten RA; Ruggeri ZM
J Biol Chem; 1990 Jan; 265(1):274-80. PubMed ID: 2104618
[TBL] [Abstract][Full Text] [Related]
9. Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4, which inhibits both ristocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib.
Fujimura Y; Usami Y; Titani K; Niinomi K; Nishio K; Takase T; Yoshioka A; Fukui H
Blood; 1991 Jan; 77(1):113-20. PubMed ID: 1984791
[TBL] [Abstract][Full Text] [Related]
10. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation.
Andrews RK; Kroll MH; Ward CM; Rose JW; Scarborough RM; Smith AI; López JA; Berndt MC
Biochemistry; 1996 Sep; 35(38):12629-39. PubMed ID: 8823201
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib.
Fujimura Y; Ikeda Y; Miura S; Yoshida E; Shima H; Nishida S; Suzuki M; Titani K; Taniuchi Y; Kawasaki T
Thromb Haemost; 1995 Aug; 74(2):743-50. PubMed ID: 8585016
[TBL] [Abstract][Full Text] [Related]
12. Functional modulation of the isolated glycoprotein Ib binding domain of von Willebrand factor expressed in Escherichia coli.
Sugimoto M; Ricca G; Hrinda ME; Schreiber AB; Searfoss GH; Bottini E; Ruggeri ZM
Biochemistry; 1991 May; 30(21):5202-9. PubMed ID: 2036386
[TBL] [Abstract][Full Text] [Related]
13. The von willebrand factor domain-mediating botrocetin-induced binding to glycoprotein IB lies between Val449 and Lys728.
Fujimura Y; Holland LZ; Ruggeri ZM; Zimmerman TS
Blood; 1987 Oct; 70(4):985-8. PubMed ID: 3498523
[TBL] [Abstract][Full Text] [Related]
14. Inhibition assay for the binding of biotinylated von Willebrand factor to platelet-bound microtiter wells in the presence of ristocetin or botrocetin.
Miura S; Nishida S; Makita K; Sakurai Y; Shimoyama T; Sugimoto M; Yoshioka A; Ishii K; Kito M; Kobayashi T; Fujimura Y
Anal Biochem; 1996 May; 236(2):215-20. PubMed ID: 8660497
[TBL] [Abstract][Full Text] [Related]
15. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
[TBL] [Abstract][Full Text] [Related]
16. Enhanced botrocetin-induced type IIB von Willebrand factor binding to platelet glycoprotein Ib initiates hyperagglutination of normal platelets.
Nishio K; Fujimura Y; Niinomi K; Takahashi Y; Yoshioka A; Fukui H; Usami Y; Titani K; Ruggeri ZM; Zimmerman TS
Am J Hematol; 1990 Apr; 33(4):261-6. PubMed ID: 2316510
[TBL] [Abstract][Full Text] [Related]
17. Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of von Willebrand factor binding to platelet glycoprotein Ib.
Sugimoto M; Mohri H; McClintock RA; Ruggeri ZM
J Biol Chem; 1991 Sep; 266(27):18172-8. PubMed ID: 1917949
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Binding of von Willebrand Factor to the Platelet Glycoprotein Ib-IX Complex, Heparin and Sulfatides by Polyanionic Compounds. The Mechanism of Modulation of the Adhesive Function of von Willebrand Factor.
Andrews RK; Bendall LJ; Booth WJ; Berndt MC
Platelets; 1995; 6(5):252-8. PubMed ID: 21043709
[TBL] [Abstract][Full Text] [Related]
19. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
[TBL] [Abstract][Full Text] [Related]
20. Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination.
Matsui T; Hori A; Hamako J; Matsushita F; Ozeki Y; Sakurai Y; Hayakawa M; Matsumoto M; Fujimura Y
J Thromb Haemost; 2017 Mar; 15(3):538-548. PubMed ID: 28071872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]